Search for other papers by Giorgio Bedogni in
Google Scholar
PubMed
Search for other papers by Andrea Mari in
Google Scholar
PubMed
Search for other papers by Alessandra De Col in
Google Scholar
PubMed
Search for other papers by Sofia Tamini in
Google Scholar
PubMed
Search for other papers by Amalia Gastaldelli in
Google Scholar
PubMed
Istituto Auxologico Italiano, IRCCS, Division of Metabolic Diseases and Auxology, Piancavallo (VB), Italy
Search for other papers by Alessandro Sartorio in
Google Scholar
PubMed
Diabetes Federation . Definition and Diagnosis of Diabetes Mellitus and Intermediate Hyperglycaemia: Report of a WHO IDF Consultation . Geneva, Switzerland: World Health Organization , 2006 . 10 Bedogni G Gastaldelli A Manco M De Col A Agosti
Search for other papers by Po-Chung Cheng in
Google Scholar
PubMed
Search for other papers by Chia-Hung Kao in
Google Scholar
PubMed
– 3209 . ( https://doi.org/10.1016/j.jacc.2018.11.002 ) 10 Fuller JH McCartney P Jarrett RJ Keen H Rose G Shipley MJ Hamilton PJ . Hyperglycaemia and coronary heart disease: the Whitehall study . Journal of Chronic Diseases 1979 32
Search for other papers by Huguette S Brink in
Google Scholar
PubMed
Search for other papers by Aart Jan van der Lely in
Google Scholar
PubMed
Search for other papers by Joke van der Linden in
Google Scholar
PubMed
of obesity and T2DM in children ( 11 , 22 ), who are eight times more likely to develop T2DM than non-GD children ( 23 ). Therefore, there is a strong need for early detection of GD. Detection preceding the hyperglycaemia might avoid subsequent harm
Search for other papers by Sakina H Bharmal in
Google Scholar
PubMed
Search for other papers by Wandia Kimita in
Google Scholar
PubMed
Search for other papers by Juyeon Ko in
Google Scholar
PubMed
Search for other papers by Maxim S Petrov in
Google Scholar
PubMed
. The used thresholds were in line with the DEP criteria ( 19 ). Given that FPG > 5.6 mmol/L (100 mg/dL) at baseline might be due to stress hyperglycaemia ( 20 ), FPG at baseline was not taken into consideration in grouping the study participants
Zealand Pharma A/S, Søborg, Denmark
Search for other papers by Iben Rix in
Google Scholar
PubMed
Search for other papers by Marie L Johansen in
Google Scholar
PubMed
Search for other papers by Asger Lund in
Google Scholar
PubMed
Search for other papers by Malte P Suppli in
Google Scholar
PubMed
Search for other papers by Elizaveta Chabanova in
Google Scholar
PubMed
Department of Biomedical Sciences, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
Search for other papers by Gerrit van Hall in
Google Scholar
PubMed
Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
Search for other papers by Jens J Holst in
Google Scholar
PubMed
Department of Clinical Biochemistry, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark
Novo Nordisk Foundation Center for Protein Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
Search for other papers by Nicolai J Wewer Albrechtsen in
Google Scholar
PubMed
Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
Search for other papers by Caroline Kistorp in
Google Scholar
PubMed
Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
Steno Diabetes Center Copenhagen, Herlev, Denmark
Search for other papers by Filip K Knop in
Google Scholar
PubMed
Introduction Hyperglucagonaemia contributes to the hyperglycaemia characterizing type 2 diabetes (T2D) ( 1 , 2 ). Nevertheless, high glucagon concentrations are observed in some, but not all individuals with T2D, indicating that
Department of Clinical Research, University of Southern Denmark, Odense, Denmark
Search for other papers by Maria Houborg Petersen in
Google Scholar
PubMed
Search for other papers by Jacob Volmer Stidsen in
Google Scholar
PubMed
Department of Sports Science and Clinical Biomechanics, University of Southern Denmark, Odense, Denmark
Search for other papers by Martin Eisemann de Almeida in
Google Scholar
PubMed
Search for other papers by Emil Kleis Wentorf in
Google Scholar
PubMed
Search for other papers by Kurt Jensen in
Google Scholar
PubMed
Search for other papers by Niels Ørtenblad in
Google Scholar
PubMed
Department of Clinical Research, University of Southern Denmark, Odense, Denmark
Search for other papers by Kurt Højlund in
Google Scholar
PubMed
Molecular Sciences 2020 21 . ( https://doi.org/10.3390/ijms21176275 ) 2 Davies MJ Aroda VR Collins BS Gabbay RA Green J Maruthur NM Rosas SE Del Prato S Mathieu C Mingrone G , et al. Management of hyperglycaemia in type 2 diabetes
Search for other papers by Jan W Eriksson in
Google Scholar
PubMed
Search for other papers by Reem A Emad in
Google Scholar
PubMed
Search for other papers by Martin H Lundqvist in
Google Scholar
PubMed
Search for other papers by Niclas Abrahamsson in
Google Scholar
PubMed
Search for other papers by Maria C Kjellsson in
Google Scholar
PubMed
Eriksson JW . Altered hormonal and autonomic nerve responses to hypo- and hyperglycaemia are found in overweight and insulin-resistant individuals and may contribute to the development of type 2 diabetes . Diabetologia 2021 64 641 – 655 . ( https
Department of Endocrinology and Diabetes, Pakistan Kidney and Liver Institute and Research Centre, Knowledge City, Lahore, Pakistan
Search for other papers by Zeeshan Javed in
Google Scholar
PubMed
Division of Bone Diseases, Geneva University Hospitals and Faculty of Medicine, University of Geneva, Geneva, Switzerland
Search for other papers by Maria Papageorgiou in
Google Scholar
PubMed
Search for other papers by Leigh A Madden in
Google Scholar
PubMed
Search for other papers by Alan S Rigby in
Google Scholar
PubMed
Search for other papers by Eric S Kilpatrick in
Google Scholar
PubMed
Search for other papers by Stephen L Atkin in
Google Scholar
PubMed
Search for other papers by Thozhukat Sathyapalan in
Google Scholar
PubMed
hyperglycaemia: the pleiotropic effects of SGLT2 inhibition . Diabetologia 2017 60 215 – 225 . ( https://doi.org/10.1007/s00125-016-4157-3 ) 27 Zinman B Wanner C Lachin JM Fitchett D Bluhmki E Hantel S Mattheus M Devins T Johansen OE
Search for other papers by Hathairat Rueangdetnarong in
Google Scholar
PubMed
Search for other papers by Rattanaporn Sekararithi in
Google Scholar
PubMed
Search for other papers by Thidarat Jaiwongkam in
Google Scholar
PubMed
Search for other papers by Sirinart Kumfu in
Google Scholar
PubMed
Search for other papers by Nipon Chattipakorn in
Google Scholar
PubMed
Search for other papers by Theera Tongsong in
Google Scholar
PubMed
Search for other papers by Phudit Jatavan in
Google Scholar
PubMed
edited the manuscript. References 1 Linnenkamp U Guariguata L Beagley J Whiting DR Cho NH. The IDF Diabetes Atlas methodology for estimating global prevalence of hyperglycaemia in pregnancy . Diabetes Research and Clinical Practice
Search for other papers by Tsung-Hui Wu in
Google Scholar
PubMed
Search for other papers by Guan-Yu Su in
Google Scholar
PubMed
Search for other papers by Tsung-Yun Liu in
Google Scholar
PubMed
Institute of Pharmacology, College of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan
PhD Program in Toxicology, Kaohsiung Medical University, Kaohsiung, Taiwan
Search for other papers by Hsiang-Tsui Wang in
Google Scholar
PubMed
Faculty of Medicine, National Yang Ming Chiao Tung University School of Medicine, Taipei, Taiwan
Search for other papers by Chii-Min Hwu in
Google Scholar
PubMed
WC Genuth S Grimm RH , Effect of intensive treatment of hyperglycaemia on microvascular outcomes in type 2 diabetes: an analysis of the Accord randomised trial . Lancet 2010 376 419 – 430 . ( https://doi.org/10.1016/S0140-6736(1060576-4 ) 31